Target intelligence / Profile preview

Actin filament-associated protein 1 (AFAP1)

Target
AFAP1
Molecular classification
Other (Adaptor protein), Cytoskeletal linker protein, Pleckstrin homology domain-containing protein
01

Overview

Actin filament-associated protein 1 (AFAP1) is an adaptor and scaffold protein that interacts with actin filaments and links them to key signaling molecules, notably the SRC family kinases and protein kinase C. AFAP1 modulates cytoskeletal integrity and dynamics in response to cellular signals, promoting the assembly of structures crucial for cell adhesion, migration, and invasion such as podosomes and focal adhesions[1][2][3]. It plays an important regulatory role in cancer cell motility and has been implicated in tumor progression and metastasis[2][3]. Additionally, the AFAP1 gene locus encodes an antisense long non-coding RNA (AFAP1-AS1) that acts as an oncogenic regulator in various tumors[1][4]. AFAP1 is mainly classified as a cytoskeletal adaptor protein rather than a classic enzyme, transporter, or receptor, but its involvement in signal transduction and cancer biology makes it a potential therapeutic target.

Other names
AFAP-110AFAPAFAP110110 kDa actin filament-associated proteinActin filament-associated protein, 110 kDa
02

Mechanism of action

No direct small molecule inhibitors reported; the protein acts chiefly as a scaffold/adaptor influencing downstream signaling such as SRC and protein kinase C pathways[1][2][3].

03

Biological functions

Actin cytoskeleton organizationSignal transductionCell adhesionCell migrationCell invasionRegulation of cell structure and morphologyModulation of stress fibers, podosomes, and focal adhesions
04

Disease associations

Cancer (including breast, prostate, and possibly other solid tumors)MetastasisPotential involvement in ocular diseases such as glaucoma
05

Safety considerations

Targeting adaptors/scaffold proteins may disrupt essential physiological actin-based processes in normal tissues.Possible impact on normal cell adhesion and immune cell migration due to broad cytoskeletal role.
06

Biomarkers

Increased AFAP1 expression associated with cancer progression and metastatic potential[2][3].Overexpression of antisense RNA (AFAP1-AS1) in various cancers indicates poor prognosis[2][4].

Beyond the preview

Go deeper on Actin filament-associated protein 1 (AFAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin filament-associated protein 1 (AFAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call